Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation
Authors:
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer
- Vol. 38 (13) , 1724-1729
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Topotecan Versus Observation After Cisplatin Plus Etoposide in Extensive-Stage Small-Cell Lung Cancer: E7593—A Phase III Trial of the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 2001
- 1038: Topotecan (Hycamtin™) in small cell lung cancer (SCLC) after failure of first line therapy: Multicentre phase II studyEuropean Journal of Cancer, 1997
- Clinical Pharmacokinetics of TopotecanClinical Pharmacokinetics, 1996
- Response of Brain Metastases from Lung Cancer to Systemic Chemotherapy with Carboplatin and EtoposideOncology, 1996
- Interaction of topoisomerase I inhibitors with radiation in cis‐diamminedichloroplatinum(II)‐sensitive and ‐resistantcells In Vitro and in the fsaiic fibrosarcoma In VivoInternational Journal of Cancer, 1993
- Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancerEuropean Journal of Cancer, 1993
- Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude miceInternational Journal of Cancer, 1992
- Metastatic Brain TumorsContemporary Neurosurgery, 1990
- Teniposide (VM26): An effective treatment for brain metastases of small cell carcinoma of the lungEuropean Journal of Cancer and Clinical Oncology, 1988
- Brain metastases from small cell lung cancer treated with combination chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1988